Physician profile
Ashley Skipper
NPI 1508305673
$10,465.87
in general payments reported to CMS, 2019-2025
59 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,755 · 2022: $2,656 · 2023: $2,501 · 2024: $1,896 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,054.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,478.43 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $1,374.81 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $753.63 | 2021-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Glaxosmithkline, LLC. | $593.84 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Exact Sciences Corporation | $592.23 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $564.23 | 2021-2023 | Breztri |
| Abbvie INC. | $526.80 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $433.33 | 2022-2025 | Entyvio, Trintellix |
| Pfizer INC. | $294.43 | 2021-2025 | |
| Amgen INC. | $272.15 | 2021-2024 | Repatha, Otezla |
| Teva Pharmaceuticals USA, INC. | $256.20 | 2021-2022 | |
| Abbott Laboratories | $224.25 | 2022-2025 | Freestyle Libre 3, Octrode |
| Daiichi Sankyo INC. | $211.27 | 2022-2025 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $199.02 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $195.19 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $171.28 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $159.57 | 2022-2025 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.17 | 2021-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $140.31 | 2021-2023 | |
| Dexcom, INC. | $136.24 | 2022-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $133.61 | 2022-2024 | |
| Boston Scientific Corporation | $119.68 | 2025 | Watchman |
| Regeneron Healthcare Solutions, INC. | $113.32 | 2024-2025 | Dupixent |
| Janssen Pharmaceuticals, INC | $107.74 | 2021-2023 | Xarelto |
| Genzyme Corporation | $96.31 | 2024 | |
| Astellas Pharma US INC | $88.50 | 2021-2024 | Veozah |
| Idorsia Pharmaceuticals US INC | $72.48 | 2022-2023 | Quviviq |
| Sanofi-Aventis U.S. LLC | $66.12 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $65.38 | 2022-2023 | Rexulti |
| Phathom Pharmaceuticals, INC. | $64.73 | 2023-2025 | Voquezna |
| Gilead Sciences, INC. | $63.82 | 2022 | |
| Axsome Therapeutics, INC. | $57.38 | 2023-2025 | Auvelity, Symbravo |
| Collegium Pharmaceutical, INC. | $54.23 | 2023-2024 | Xtampza, Belbuca |
| Edwards Lifesciences Corporation | $48.73 | 2023 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Aimmune Therapeutics, INC. | $48.01 | 2025 | Zenpep |
| Corcept Therapeutics | $46.36 | 2025 | Korlym |
| Jazz Pharmaceuticals INC. | $38.55 | 2022 | |
| Inogen, INC. | $37.15 | 2022 | |
| Eisai INC. | $34.13 | 2022 | |
| Grifols USA, LLC | $32.21 | 2021-2025 | Prolastin-C Liquid |
| Horizon Therapeutics Plc | $31.30 | 2022-2023 | Krystexxa |
| Madrigal Pharmaceuticals | $30.61 | 2025 | Rezdiffra |
| Lundbeck LLC | $25.53 | 2023 | Rexulti |
| Ironwood Pharmaceuticals, INC | $21.56 | 2024 | |
| Shield Therapeutics INC | $19.69 | 2023 | Accrufer |
| Impel Pharmaceuticals INC. | $19.36 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $18.02 | 2022 | |
| Seqirus USA INC | $17.16 | 2025 | Flucelvax, Fluad |
| Amphastar Pharmaceuticals, INC. | $16.74 | 2025 | |
| Insulet Corporation | $16.32 | 2025 | Omnipod |
| Sumitomo Pharma America, INC. | $16.09 | 2025 | Gemtesa |
| Ardelyx, INC. | $15.91 | 2024 | Ibsrela |
| Ferring Pharmaceuticals INC. | $15.67 | 2024 | Rebyota |
| Hikma Pharmaceuticals USA | $15.45 | 2023 | Ryaltris |
| Alkermes, INC. | $15.30 | 2023 | Vivitrol |
| Vanda Pharmaceuticals INC. | $14.61 | 2022 | |
| Dentsply Sirona INC | $14.26 | 2023 | Consumable Dentistry |
| Biogen, INC. | $14.22 | 2025 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Skipper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.